The development of ZnO-based biosensors targeting CYFRA 21-1 represents a significant advancement in cancer detection technology. With its potential for rapid, sensitive, and noninvasive screening ...

Former President Joe Biden's prostate cancer diagnosis is highlighting the importance of screening for one of the most common ...

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Zoono Group Limited (ZNO). However, you won't necessarily see their names in the company’s ...